Aligned Genetics, Inc. (KOSDAQ:238120)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,035.00
-90.00 (-2.88%)
At close: Aug 18, 2026

Aligned Genetics Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
10,67014,61810,13914,92710,6966,137
Short-Term Investments
4,000-7,500-3,0007,000
Cash & Short-Term Investments
14,67014,61817,63914,92713,69613,137
Cash Growth
-16.47%-17.13%18.17%8.99%4.25%8.22%
Accounts Receivable
2,3222,6232,8552,6671,4512,130
Other Receivables
620.63395.5196.3755.6417.55293.91
Receivables
3,0043,0793,3312,7231,4692,424
Inventory
5,4024,9844,1983,8523,7592,353
Prepaid Expenses
477.63100.58130.0713.01343.1158.1
Other Current Assets
124.2339.95268.188.1284.98413.05
Total Current Assets
23,67722,82225,56721,60319,55218,386
Property, Plant & Equipment
20,37919,8357,7708,0357,2855,776
Long-Term Investments
7,4927,8808,0588,5847,2337,744
Other Intangible Assets
227.42202.04131.5331.0364.35101.08
Long-Term Deferred Tax Assets
2,3242,1941,8422,0642,0431,780
Long-Term Deferred Charges
-----0
Other Long-Term Assets
4,7854,801858.17600.51723.89683.35
Total Assets
58,96257,79544,27540,93236,90134,469

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
92.44153.797.48164.9134.26144.46
Accrued Expenses
338.54365.33234.02130.05277.79150.37
Current Portion of Long-Term Debt
2,5202,520-3,900--
Current Portion of Leases
179.6648.32173.94175.47235.32214.76
Current Income Taxes Payable
25.5519.0979.8877.487.32-
Current Unearned Revenue
---9.86--
Other Current Liabilities
1,6281,3841,311780.35598.52907.73
Total Current Liabilities
4,7844,4901,8965,2381,3331,417
Long-Term Debt
11,82011,8502,400-3,9003,900
Long-Term Leases
508.0686.35389.6587.61243.97320.97
Pension & Post-Retirement Benefits
3,9983,9073,7603,5102,4221,741
Long-Term Deferred Tax Liabilities
5.014.75----
Other Long-Term Liabilities
295.8295.8335.45284.31152.4998.52
Total Liabilities
21,41120,6338,7819,6208,0527,477

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
7,1897,1897,1897,1893,5953,595
Additional Paid-In Capital
22,64622,64622,64622,64626,25926,259
Retained Earnings
9,3868,9685,8511,680-1,202-2,936
Treasury Stock
-997.53-997.53----
Comprehensive Income & Other
-672.74-644.61-191.59-203.85197.974.85
Shareholders' Equity
37,55137,16135,49431,31128,85026,992
Total Liabilities & Equity
58,96257,79544,27540,93236,90134,469

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
15,02814,5052,9644,6634,3794,436
Net Cash (Debt)
-358.04113.0114,67610,2649,3178,701
Net Cash Growth
--99.23%42.98%10.17%7.07%-20.97%
Net Cash Per Share
-25.438.011020.31713.81647.93605.15
Filing Date Shares Outstanding
14.0614.0614.3814.3814.3814.38
Total Common Shares Outstanding
14.0614.0614.3814.3814.3814.38
Working Capital
18,89418,33223,67116,36518,21916,968
Book Value Per Share
2671.082643.382468.502177.602006.391877.21
Tangible Book Value
37,32336,95935,36331,28028,78526,891
Tangible Book Value Per Share
2654.912629.012459.362175.442001.921870.18
Land
7,5547,5541,5571,557-1,557
Buildings
9,0689,0682,9742,974-2,974
Machinery
3,1253,0442,7342,502-2,001
Construction In Progress
2,8152,7862,3382,278--